Amanote Research
Register
Sign In
Pin56 - Cost-Effectiveness of Varicella and Herpes Zoster Vaccination in the Swedish Population
Value in Health
- United Kingdom
doi 10.1016/j.jval.2018.09.1375
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
October 1, 2018
Authors
E. Wolff
Publisher
Elsevier BV
Related search
Cost-Effectiveness Assessment of Herpes Zoster Vaccination in Germany
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Distribution of Health Effects and Cost-Effectiveness of Varicella Vaccination Are Shaped by the Impact on Herpes Zoster
EBioMedicine
Biochemistry
Medicine
Genetics
Molecular Biology
The Epidemiology of Varicella and Herpes Zoster in the Netherlands: Implications for Varicella Zoster Virus Vaccination
Vaccine
Molecular Medicine
Public Health
Veterinary
Microbiology
Environmental
Immunology
Infectious Diseases
Occupational Health
Herpes Zoster and Varicella
BMJ
The Impact of Demographic Changes, Exogenous Boosting and New Vaccination Policies on Varicella and Herpes Zoster in Italy: A Modelling and Cost-Effectiveness Study
BMC Medicine
Medicine
Dentistry, Herpes Zoster, and Varicella.
BMJ
Concurrent Herpes Zoster and Varicella
BMJ
PIN63 Vaccination Against Herpes Zoster and Post-Herpetic Neuralgia in France: A Cost-Effectiveness Analysis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Epidemiology and Costs of Varicella and Herpes Zoster in Germany
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
